Found: 106
Select item for more details and to access through your institution.
Targeted alpha therapy with bismuth‐213 and actinium‐225: Meeting future demand.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2019, v. 62, n. 11, p. 794, doi. 10.1002/jlcr.3792
- By:
- Publication type:
- Article
Development of [ 225 Ac]Ac-PSMA-I&T for Targeted Alpha Therapy According to GMP Guidelines for Treatment of mCRPC.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 5, p. 715, doi. 10.3390/pharmaceutics13050715
- By:
- Publication type:
- Article
Carbonic Anhydrase IX-Targeted α-Radionuclide Therapy with 225Ac Inhibits Tumor Growth in a Renal Cell Carcinoma Model.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 5, p. 570, doi. 10.3390/ph15050570
- By:
- Publication type:
- Article
In vitro evaluation of <sup>225</sup>Ac‐DOTA‐substance P for targeted alpha therapy of glioblastoma multiforme.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 1, p. 1344, doi. 10.1111/cbdd.13199
- By:
- Publication type:
- Article
Functionalized NaA nanozeolites labeled with <sup>224,225</sup>Ra for targeted alpha therapy.
- Published in:
- Journal of Nanoparticle Research, 2013, v. 15, n. 11, p. 1, doi. 10.1007/s11051-013-2082-7
- By:
- Publication type:
- Article
First preclinical evaluation of [<sup>225</sup>Ac]Ac-DOTA-JR11 and comparison with [<sup>177</sup>Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETs.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2023, v. 8, n. 1, p. 1, doi. 10.1186/s41181-023-00197-0
- By:
- Publication type:
- Article
First‐Generation Bispidine Chelators for <sup>213</sup>Bi<sup>III</sup> Radiopharmaceutical Applications.
- Published in:
- ChemMedChem, 2020, v. 15, n. 16, p. 1591, doi. 10.1002/cmdc.202000361
- By:
- Publication type:
- Article
Radio-immunothérapie alpha.
- Published in:
- Médecine Sciences, 2016, v. 32, n. 4, p. 362, doi. 10.1051/medsci/20163204014
- By:
- Publication type:
- Article
Interaction of Radiolabeled Antibodies with Fungal Cells and Components of the Immune System In Vitro and during Radioimmunotherapy for Experimental Fungal Infection.
- Published in:
- Journal of Infectious Diseases, 2006, v. 193, n. 10, p. 1427, doi. 10.1086/503369
- By:
- Publication type:
- Article
Magnetic Memory Effect in a Transuranic Mononuclear Complex.
- Published in:
- Angewandte Chemie, 2011, v. 123, n. 7, p. 1734, doi. 10.1002/ange.201006619
- By:
- Publication type:
- Article
Titelbild: [An(H<sub>2</sub>O)<sub>9</sub>](CF<sub>3</sub>SO<sub>3</sub>)<sub>3</sub> (An=U-Cm, Cf): Exploring Their Stability, Structural Chemistry, and Magnetic Behavior by Experiment and Theory (Angew. Chem. 36/2010).
- Published in:
- Angewandte Chemie, 2010, v. 122, n. 36, p. 6367, doi. 10.1002/ange.201003226
- By:
- Publication type:
- Article
[An(H<sub>2</sub>O)<sub>9</sub>](CF<sub>3</sub>SO<sub>3</sub>)<sub>3</sub> (An=U-Cm, Cf): Exploring Their Stability, Structural Chemistry, and Magnetic Behavior by Experiment and Theory.
- Published in:
- Angewandte Chemie, 2010, v. 122, n. 36, p. 6487, doi. 10.1002/ange.201001077
- By:
- Publication type:
- Article
Functionalized TiO<sub>2</sub> nanoparticles labelled with <sup>225</sup>Ac for targeted alpha radionuclide therapy.
- Published in:
- Journal of Nanoparticle Research, 2018, v. 20, n. 3, p. 1, doi. 10.1007/s11051-018-4181-y
- By:
- Publication type:
- Article
Pre-clinical Study of <sup>213</sup>Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer.
- Published in:
- Clinical & Experimental Metastasis, 2005, v. 22, n. 7, p. 575, doi. 10.1007/s10585-005-5788-9
- By:
- Publication type:
- Article
Combining α-Radioimmunotherapy and Adoptive T Cell Therapy to Potentiate Tumor Destruction.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130249
- By:
- Publication type:
- Article
DNA Double Strand Breaks as Predictor of Efficacy of the Alpha-Particle Emitter Ac-225 and the Electron Emitter Lu-177 for Somatostatin Receptor Targeted Radiotherapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088239
- By:
- Publication type:
- Article
Alpha-Particle Emitting <sup>213</sup>Bi-Anti-EGFR Immunoconjugates Eradicate Tumor Cells Independent of Oxygenation
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064730
- By:
- Publication type:
- Article
Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide <sup>213</sup>Bi-DTPA-[F3]<sub>2</sub> into the Nucleus of Tumor Cells.
- Published in:
- PLoS ONE, 2009, v. 4, n. 5, p. 1, doi. 10.1371/journal.pone.0005715
- By:
- Publication type:
- Article
Radioimmunotherapy is more effective than antifungal treatment in experimental cryptococcal infection.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Radioimmunotherapy Is More Effective than Antifungal Treatment in Experimental Cryptococcal Infection.
- Published in:
- Journal of Infectious Diseases, 2010, v. 202, n. 4, p. 633, doi. 10.1086/654813
- By:
- Publication type:
- Article
Evaluation of the tolerability and safety of [<sup>225</sup>Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11900-y
- By:
- Publication type:
- Article
In vitro studies of <sup>223</sup>Ra- and <sup>225</sup>Ac-labelled α-zirconium phosphate as potential carrier for alpha targeted therapy.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2023, v. 332, n. 5, p. 1527, doi. 10.1007/s10967-022-08742-y
- By:
- Publication type:
- Article
Preparation and characterization of α-zirconium phosphate as a perspective material for separation of <sup>225</sup>Ac and <sup>213</sup>Bi.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2023, v. 332, n. 5, p. 1475, doi. 10.1007/s10967-022-08682-7
- By:
- Publication type:
- Article
Separation of <sup>221</sup>Fr from <sup>225</sup>Ac using diglycolamide solid extractants.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2023, v. 332, n. 5, p. 1483, doi. 10.1007/s10967-022-08571-z
- By:
- Publication type:
- Article
Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1256, doi. 10.3390/cancers13061256
- By:
- Publication type:
- Article
Preclinical Targeted α- and β−-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain Antibodies.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1017, doi. 10.3390/cancers12041017
- By:
- Publication type:
- Article
Zur Elektronenstruktur metallorganischer Komplexe der f-Elemente. 60 [1] Strukturelle, einkristalloptische und magnetooptische Untersuchungen von Trialkylphosphat-Addukten des Grundkörpers Tris(cyclopentadienyl)lanthanid(III) (Ln = La, Pr) sowie Ergebnisse vergleichender optischer Studien an [Pr(Ind)<sub>3</sub>(OP(OEt)<sub>3</sub>)] (Ind = Indenyl)
- Published in:
- Zeitschrift für Anorganische und Allgemeine Chemie, 2004, v. 630, n. 6, p. 928, doi. 10.1002/zaac.200400044
- By:
- Publication type:
- Article
Quantitative SPECT/CT imaging of actinium-225 for targeted alpha therapy of glioblastomas.
- Published in:
- EJNMMI Physics, 2024, v. 11, n. 1, p. 1, doi. 10.1186/s40658-024-00635-1
- By:
- Publication type:
- Article
<sup>213</sup>Bi-radioimmunotherapy defeats early-stage disseminated gastric cancer in nude mice.
- Published in:
- Cancer Science, 2007, v. 98, n. 8, p. 1215, doi. 10.1111/j.1349-7006.2007.00525.x
- By:
- Publication type:
- Article
Cover Feature: Dual‐Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy (Chem. Eur. J. 3/2018).
- Published in:
- 2018
- By:
- Publication type:
- Cover Art
Dual‐Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.
- Published in:
- Chemistry - A European Journal, 2018, v. 24, n. 3, p. 547, doi. 10.1002/chem.201702335
- By:
- Publication type:
- Article
Enhanced efficacy of combined Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 12, p. 1886, doi. 10.1007/s00259-012-2203-z
- By:
- Publication type:
- Article
Therapeutic efficacy and toxicity of Ac-labelled vs. Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 4, p. 602, doi. 10.1007/s00259-011-2023-6
- By:
- Publication type:
- Article
Therapeutic efficacy and toxicity of Ac-labelled vs. Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2012, v. 39, n. 4, p. 602, doi. 10.1007/s00259-011-2023-6
- By:
- Publication type:
- Article
Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in α-emitter therapy for disseminated ovarian cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2008, v. 35, n. 1, p. 53, doi. 10.1007/s00259-007-0582-3
- By:
- Publication type:
- Article
Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after <sup>213</sup>Bi-radioimmunotherapy using bioluminescence imaging.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 6, p. 841, doi. 10.1007/s00259-006-0311-3
- By:
- Publication type:
- Article
Prostat Kanserinin Hedefe Yönelik Alfa-Radyonüklit Tedavisinde Ac-225-PSMA'nın In Vitro ve In Vivo Değerlendirilmesi.
- Published in:
- Nuclear Medicine Seminars, 2019, v. 5, p. 3
- By:
- Publication type:
- Article
Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: towards improved alpha-therapeutics.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0431-3
- By:
- Publication type:
- Article
Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model.
- Published in:
- EJNMMI Research, 2017, v. 7, n. 1, p. 1, doi. 10.1186/s13550-017-0303-2
- By:
- Publication type:
- Article
Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the Bi-labeled monoclonal antibody MX35 in an ovarian cancer model.
- Published in:
- EJNMMI Research, 2017, v. 7, n. 1, p. 1, doi. 10.1186/s13550-017-0283-2
- By:
- Publication type:
- Article
Influence of tumour size on the efficacy of targeted alpha therapy with Bi-[DOTA,Tyr]-octreotate.
- Published in:
- EJNMMI Research, 2016, v. 6, n. 1, p. 1, doi. 10.1186/s13550-016-0162-2
- By:
- Publication type:
- Article
Deescalated <sup>225</sup>Ac-PSMA-617 Versus <sup>177</sup>Lu/<sup>225</sup>Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267206
- By:
- Publication type:
- Article
Deescalated <sup>225</sup>Ac-PSMA-617 Versus <sup>177</sup>Lu/<sup>225</sup>Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 7, p. 1057, doi. 10.2967/jnumed.123.267206
- By:
- Publication type:
- Article
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 685, doi. 10.2967/jnumed.122.265353
- By:
- Publication type:
- Article
Targeted α-Therapy Using <sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 751, doi. 10.2967/jnumed.122.264752
- By:
- Publication type:
- Article
mCRPC patients receiving 225Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article
mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article
mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article
mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article
mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article